The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD2 or PGE2

被引:2
|
作者
Okura, Iori [1 ]
Hasuoka, Nanae [2 ,3 ]
Senoo, Kanaho [2 ,3 ]
Suganami, Akiko [4 ]
Fukushima, Keijo [2 ,3 ]
Regan, John W. [5 ]
Mashimo, Masato [6 ]
Murayama, Toshihiko [1 ]
Tamura, Yutaka [4 ]
Fujino, Hiromichi [2 ,3 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan
[2] Tokushima Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol Life Sci, Tokushima 7708505, Japan
[3] Tokushima Univ, Grad Sch Biomed Sci, Tokushima 7708505, Japan
[4] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba 2608670, Japan
[5] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[6] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Pharmacol Lab, Kyoto 6100311, Japan
关键词
Human DP receptors; Human EP2 receptors; PGD(2); PGE(2); PDE4; PROSTAGLANDIN RECEPTOR; ASSOCIATION; CLONING; GENE;
D O I
10.1007/s43440-021-00247-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Human DP and EP2 receptors are two of the most homologically related receptors coupling with G(alpha)s-protein, which stimulate adenylyl cyclase to produce cAMP. Indeed, both receptors are considered to be generated by tandem duplication. It has been reported that other highly homologous and closely related beta 1- and beta 2-adrenergic receptors interact distinctly with and differentially regulate cAMP-specific phosphodiesterase (PDE) 4 recruitment. Methods First, we focused on the cAMP degradation pathways of DP and EP2 receptors stimulated by prostaglandin (PG) D-2 or PGE(2) using HEK cells stably expressing either human DP receptors or EP2 receptors. Then, distances between ligands and amino acids of the receptors were evaluated by molecular dynamics (MD) analysis. Results We found that PGD(2)/EP2 receptors exerted a greater effect on PDE4 activity than PGE(2)/EP2 receptors. Moreover, by MD analysis, either the PGD(2) or EP2 receptor was moved and the distance was shortened between them. According to the results, DP receptors retain reactivity for PGE(2), but EP2 receptors may be activated only by PGE(2), at least in terms of cAMP formation, through the differential functional coupling of PDE4 probably with beta-arrestin. Conclusion Since DP receptors and EP2 receptors are considered to be duplicated genes, DP receptors may still be in a rapid evolutionary stage as a duplicated copy of EP2 receptors and have not yet sufficient selectivity for their cognate ligand, PGD(2).
引用
收藏
页码:946 / 953
页数:8
相关论文
共 50 条
  • [31] Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists
    Bodder, Johanna
    Kok, Leanne M. M.
    Fauerbach, Jonathan A. A.
    Florez-Grau, Georgina
    de Vries, I. Jolanda M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [32] EP2 and EP4 prostanoid receptor signaling
    Regan, JW
    LIFE SCIENCES, 2003, 74 (2-3) : 143 - 153
  • [33] Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors
    Najarian, T
    Hardy, P
    Hou, X
    Lachapelle, J
    Doke, A
    Gobeil, F
    Roy, MS
    Chemtob, S
    PEDIATRIC RESEARCH, 2000, 47 (04) : 419A - 419A
  • [34] Preservation of neural function in the perinate by high PGE2 levels acting via EP2 receptors
    Najarian, T
    Hardy, P
    Hou, X
    Lachapelle, J
    Doke, A
    Gobeil, F
    Roy, MS
    Lachapelle, P
    Varma, DR
    Chemtob, S
    JOURNAL OF APPLIED PHYSIOLOGY, 2000, 89 (02) : 777 - 784
  • [35] Up-regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boosts the immunosuppressive activity of PGE2
    Florez-Grau, Georgina
    Cabezon, Raquel
    Borgman, Kyra J. E.
    Espana, Carolina
    Jose Lozano, Juan
    Garcia-Parajo, Maria F.
    Benitez-Ribas, Daniel
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (03) : 881 - 895
  • [36] Up-regulation of EP2 and EP3 receptors in human tolerogenic dendritic cells boost the immunosuppressive activity of PGE2
    Florez-Grau, G.
    Cabezon, R.
    Borgman, K. J. E.
    Espana, C.
    Lozano, J. J.
    Garcia-Parajo, M. F.
    Benitez-Ribas, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 : 119 - 120
  • [37] DUAL BLOCKADE OF THE EP2 AND EP4 PGE2 RECEPTORS WITH TPST-1495 IS AN OPTIMAL APPROACH FOR DRUGGING THE PROSTAGLANDIN PATHWAY
    Lopez, Justine
    Holtz, Anja
    Freund, Dave
    Burdette, Dara
    Wang, Dingzhi
    Duboise, Raymond
    Whiting, Sam
    Dubensky, Thomas
    Francica, Brian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1382 - A1382
  • [38] DUAL BLOCKADE OF THE EP2 AND EP4 PGE2 RECEPTORS WITH TPST-1495 IS AN OPTIMAL APPROACH FOR DRUGGING THE PROSTAGLANDIN PATHWAY
    Francica, Brian
    Lopez, Justine
    Holtz, Anja
    Freund, Dave
    Wang, Dingzhi
    Enstrom, Amanda
    Whiting, Sam
    Whiting, Chan
    Dubensky, Thomas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A891 - A891
  • [39] Dual blockade of the EP2 and EP4 PGE2 receptors with TPST-1495 is an optimal approach for drugging the prostaglandin pathway
    Francica, Brian
    Lopez, Justine
    Holtz, Anja
    Freund, Dave
    Wang, Dingzhi
    Enstrom, Amanda
    Dubois, Raymond
    Kipper, Francielle
    Panigrahy, Dipak
    Whiting, Chan
    Whiting, Sam
    Dubensky, Thomas W.
    CANCER RESEARCH, 2022, 82 (12)
  • [40] PGE2 enhances BMP-2-stimulated osteoblast differentiation in human bone cells through EP2/EP4-cAMP/PKA signaling pathway.
    Takiguchi, T
    Kobayashi, M
    Takada, T
    Yamaguchi, A
    Hasegawa, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S494 - S494